Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease

NCT06092125 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2300

Last updated 2025-07-16

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the application of domestic PET/MR in major brain diseases. The main questions it aims to answer are:

* Overcome the bottleneck of early accurate diagnosis and treatment in major brain diseases clinical practice.
* Promote the clinical application of domestic PET/MR, enhance international competitiveness. Participants will have a PET/MR scan of the brain.

Conditions

  • Alzheimer Disease
  • Parkinson Disease
  • Epilepsy
  • Malignant Brain Tumor

Interventions

DEVICE

PET/MR

PET/MR device is used for pre-treatment evaluation and efficacy follow-up of four types of diseases

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • Wuhan TongJi Hospital

    collaborator OTHER
  • Henan Provincial People's Hospital

    collaborator OTHER
  • Sun Yat-sen University

    collaborator OTHER
  • Shanghai East Hospital of Tongji University

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

    collaborator OTHER
  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • Jie Lu, Phd · Xuanwu Hospital of Capital Medical University

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-01
Primary Completion
2025-10-31
Completion
2028-10-31
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06092125 on ClinicalTrials.gov